Development of a Risk Predictive Model for Erectile Dysfunction at 12 Months after COVID-19 Recovery: A Prospective Observational Study - Beyond the Abstract ...

Transdermal Application of H100 Gel to the Penile Shaft in Patients with Peyronie's Disease Infiltrates the Tunica Albuginea - Beyond the Abstract ...

Does Adjuvant Immune Checkpoint Inhibition Therapy Have a Future in Operable Bladder Cancer? December 18, 2025 Real-World Comparison of Survival Outcomes Between Radical Cystectomy and Intravesical ...

Antioxidants for Male Infertility: Therapeutic Scheme and Indications. A Retrospective Single-Center Real-Life Study - Beyond the Abstract ...

Is Primary Retroperitoneal Lymph Node Dissection the Way Forward for Patients with Testicular Seminoma and Limited Retroperitoneal Metastases? - Beyond the Abstract ...

Robotic/laparoscopic prolapse repair and the role of hysteropexy: A urology perspective, "Beyond the Abstract," by Daniel S. Elliott, MD ...

Daniel Spratt and Alicia Morgans discuss clinical outcomes of patients with Gleason score 9-10 prostate cancer after definitive treatment. Long-term Survival in Men with Gleason Score 9-10 Treated ...

Ariana Smith discusses autologous pubovaginal slings for stress urinary incontinence treatment, highlighting this century-old procedure as a durable mesh-free alternative that remains underutilized in ...

Tamara Lotan delves into the evolution of pathology in the realm of urologic oncology, emphasizing the integration of digital and AI technologies. Dr. Lotan highlights how digital pathology, ...

Ashish Kamat interviews Patrick Soon-Shiong about the approval of Anktiva for bladder cancer treatment. Dr. Soon-Shiong shares his journey from pancreatic surgery at UCLA to developing this innovative ...

Pedro Barata interviews Wen Kong about lenvatinib plus tislelizumab for first-line treatment of fumarate hydratase (FH)-deficient renal cell carcinoma. Dr. Kong shares results from a single-center ...

UroToday - GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology.